Clinical trials
Completed Glioma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Amgen | 1 |
| Blaze Bioscience Inc. | 1 |
| Blueprint Medicines Corporation | 1 |
| Eli Lilly and Company | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Hoffmann-La Roche | 1 |
| Melbourne Health | 1 |
| NYU Langone Health | 1 |
| Ontario Clinical Oncology Group (OCOG) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 12 |
| Astrocytoma | 6 |
| Brain Neoplasms | 4 |
| Glioblastoma | 4 |
| Medulloblastoma | 4 |
| Oligodendroglioma | 4 |
| Central Nervous System Neoplasms | 3 |
| Ependymoma | 2 |
| Neuroblastoma | 2 |
| Recurrence | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.